Annette Swearengin

Director, Commercial Diagnostics @辉瑞

National, US

Translates commercial diagnostics strategy into field execution across pathology and laboratory networks nationwide. Leads the national ODL field team while owning data intelligence, targeting, and national laboratory commercial collaboration initiatives across Pfizer\'s oncology portfolio-Interpret and analyze third-party diagnostic data (Diaceutics and others) to identify testing gaps and modality trends — translating complex datasets into actionable ODL field targeting strategies-Develop and maintain dynamic target lists for the national ODL team based on testing rate analysis, market intelligence, and strategic priorities-Partnered cross-functionally with commercial, medical, pipeline, and laboratory stakeholders to align diagnostic initiatives with therapeutic objectives, launch readiness strategies, and evolving precision medicine priorities-Led the national ODL field team in executing biomarker testing strategies across oncology accounts — driving testing adoption and patient identification efforts to ensure eligible patients are connected to the right therapy-Developed post-acquisition operational infrastructure for the ODL function at Pfizer — including capabilities framework, field training program, and compliance and legal guardrails governing national field operations.Lead national laboratory commercial collaboration initiatives — identifying partnership opportunities, directing execution, and managing associated budget allocation-Served as primary pharma-side owner of strategic diagnostic collaborations from 2023 through early 2025 — originating partnership concepts and scopes of work with national genomic profiling and liquid biopsy organizations including Foundation Medicine, Guardant, and Caris to advance biomarker testing adoption across oncology accounts.

Trident University International

Bachelor of Science - BS

Jones County Junior College

Associates Degree

University of Mississippi

Master of Business Administration - MBA